Visit https://www.peervoice.com/VXJ860 to view the entire programme with slides. After completing “Tali Cukierman-Yaffe, MD, MSc - Beyond Metabolic Benefits: Recognising and Reducing the Risk of Stroke in Type 2 Diabetes With GLP-1 RAs”, participants will be able to: Recognise the burden of stroke in patients with type 2 diabetes mellitus (T2DM) and opportunities to improve primary and secondary prevention; Design treatment regimens for T2DM in accordance with national guidelines which will optimise cardiovascular benefits and stroke risk reduction; and Identify strategies to improve stroke prevention and use of GLP-1 receptor agonists (RAs) through collaborative multidisciplinary management.